Comparative Analysis of Legislative Requirements About Patients' Access to Biotechnological Drugs for Rare Diseases in Central and Eastern European Countries

Objectives: The aim of the study was to compare the access of patients with rare diseases (RDs) to biotechnological drugs in several Central and Eastern European countries (CEECs). We focused on the legislative pricing and reimbursement requirements, availability of biotechnological orphan medicinal...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Pharmacol
Main Authors: Kamusheva, Maria, Manova, Manoela, Savova, Alexandra T., Petrova, Guenka I., Mitov, Konstantin, Harsányi, András, Kaló, Zoltán, Márky, Kristóf, Kawalec, Pawel, Angelovska, Bistra, Lakić, Dragana, Tesar, Tomas, Draganic, Pero, Geitona, Mary, Hatzikou, Magdalini, Paveliu, Marian S., Männik, Agnes
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2018
Assuntos:
Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6062647/
https://ncbi.nlm.nih.gov/pubmed/30079023
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2018.00795
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados